These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 31996725)
21. T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study. Smolle MA; Herbsthofer L; Granegger B; Goda M; Brcic I; Bergovec M; Scheipl S; Prietl B; Pichler M; Gerger A; Rossmann C; Riedl J; Tomberger M; López-García P; El-Heliebi A; Leithner A; Liegl-Atzwanger B; Szkandera J Br J Cancer; 2021 Aug; 125(5):717-724. PubMed ID: 34127811 [TBL] [Abstract][Full Text] [Related]
22. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases. Davick JJ; Frierson HF; Smolkin M; Gru AA Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606 [TBL] [Abstract][Full Text] [Related]
23. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype. Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937 [TBL] [Abstract][Full Text] [Related]
24. Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer. Huang K; Hu M; Chen J; Wei J; Qin J; Lin S; Du H Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068143 [TBL] [Abstract][Full Text] [Related]
25. PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma. Nagarajan P; El-Hadad C; Gruschkus SK; Ning J; Hudgens CW; Sagiv O; Gross N; Tetzlaff MT; Esmaeli B Invest Ophthalmol Vis Sci; 2019 May; 60(6):2388-2398. PubMed ID: 31141610 [TBL] [Abstract][Full Text] [Related]
26. PD1/PD-L1 Expressions in Plasmablastic Lymphoma with Clinicopathological Correlation. Rosado FG; Coberly J; Gupta A; John G; Naina H; Koduru P; Chen W Ann Clin Lab Sci; 2021 Mar; 51(2):174-181. PubMed ID: 33941556 [TBL] [Abstract][Full Text] [Related]
27. CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors. Deng B; Park JH; Ren L; Yew PY; Kiyotani K; Antic T; O'Connor K; O'Donnell PH; Nakamura Y Cancer Rep (Hoboken); 2018 Jun; 1(1):e1002. PubMed ID: 32729250 [TBL] [Abstract][Full Text] [Related]
28. Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment. Lippens L; Van Bockstal M; De Jaeghere EA; Tummers P; Makar A; De Geyter S; Van de Vijver K; Hendrix A; Vandecasteele K; Denys H Int J Cancer; 2020 Jul; 147(2):554-564. PubMed ID: 32017078 [TBL] [Abstract][Full Text] [Related]
29. Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer. Jung M; Rose M; Knuechel R; Loeffler C; Muti H; Kather JN; Gaisa NT; BMC Cancer; 2023 Feb; 23(1):113. PubMed ID: 36726072 [TBL] [Abstract][Full Text] [Related]
30. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications. Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100 [TBL] [Abstract][Full Text] [Related]
31. Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR You W; Li L; Sun D; Liu X; Xia Z; Xue S; Chen B; Qin H; Ai J; Jiang H Cancer Immunol Res; 2019 Jun; 7(6):990-1000. PubMed ID: 30975694 [TBL] [Abstract][Full Text] [Related]
32. Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer. Sweis RF; Spranger S; Bao R; Paner GP; Stadler WM; Steinberg G; Gajewski TF Cancer Immunol Res; 2016 Jul; 4(7):563-8. PubMed ID: 27197067 [TBL] [Abstract][Full Text] [Related]
33. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470 [TBL] [Abstract][Full Text] [Related]
34. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients. Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578 [TBL] [Abstract][Full Text] [Related]
35. Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer. Parra ER; Jiang M; Machado-Rugolo J; Yaegashi LB; Prieto T; Farhat C; de Sá VK; Nagai MA; de Lima VCC; Takagaki T; Terra R; Fabro AT; Capelozzi VL Arch Pathol Lab Med; 2020 Oct; 144(10):1234-1244. PubMed ID: 32150457 [TBL] [Abstract][Full Text] [Related]
36. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216 [TBL] [Abstract][Full Text] [Related]
38. Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays. Schwamborn K; Ammann JU; Knüchel R; Hartmann A; Baretton G; Lasitschka F; Schirmacher P; Braunschweig T; Tauber R; Erlmeier F; Hieke-Schulz S; Weichert W Virchows Arch; 2019 Nov; 475(5):599-608. PubMed ID: 31267201 [TBL] [Abstract][Full Text] [Related]
39. Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic. Oguejiofor K; Galletta-Williams H; Dovedi SJ; Roberts DL; Stern PL; West CM Oncotarget; 2017 Feb; 8(9):14416-14427. PubMed ID: 28122336 [TBL] [Abstract][Full Text] [Related]
40. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]